Ernest C. Garcia III disposes 921,926 CVNA shares via 10b5-1 plan
Rhea-AI Filing Summary
Ernest C. Garcia III, filing for CARVANA CO. (CVNA), reported sales of 921,926 shares of Class A common stock on 09/24/2025. The sales were effected under a Rule 10b5-1 trading plan adopted December 13, 2024 and were executed from shares held indirectly in two trusts for which he serves as Investment Trustee and Co-Administrative Trustee: the Ernest Irrevocable 2004 Trust III and the Ernest C. Garcia III Multi-Generational Trust III. Multiple tranches show volume-weighted average prices and individual trade price ranges; reported VWAPs include prices such as $369.30, $370.31, $371.66, $372.42, $373.61, $374.55, $375.57, $377.04, and $378.39, with detailed per-trade ranges provided in the filing. The Form 4 was signed by Paul Breaux by power of attorney on behalf of Mr. Garcia.
Positive
- Sales were executed under a Rule 10b5-1 trading plan, indicating preplanned transactions adopted on December 13, 2024
- Trust holdings and trustee roles are disclosed, clarifying the nature of indirect beneficial ownership in the Ernest Irrevocable 2004 Trust III and the Multi-Generational Trust III
Negative
- Large aggregate disposition of 921,926 Class A shares on a single date (09/24/2025), which materially reduces insider-held shares
- Multiple sale tranches across a range of prices may increase available shares in the market on that date
Insights
TL;DR: Large insider sale executed under a pre-established 10b5-1 plan reduces insider stock position but follows an approved trading plan.
The reported disposition of 921,926 Class A shares by Ernest C. Garcia III is material in size and was executed under a 10b5-1 plan adopted on December 13, 2024, which indicates the sales were preplanned and not contemporaneous with nonpublic company developments. The shares sold were held indirectly in two trusts where Mr. Garcia is Investment Trustee and Co-Administrative Trustee, which preserves clarity on beneficial ownership. From a governance perspective, use of a documented 10b5-1 plan is a standard compliance mechanism that mitigates concerns about opportunistic insider sales; however, the magnitude of the sale is consequential for ownership metrics and should be monitored alongside other insider transactions.
TL;DR: Significant single-day sales at mid-$370s per share, executed across multiple trades, reduce insider holdings but reflect orderly liquidation under a plan.
The Form 4 shows dispositions across multiple price points with volume-weighted average prices reported and specific trade ranges disclosed. The total disposed amount of 921,926 shares on 09/24/2025 is sizable and may affect near-term float dynamics depending on overall share base, though the filing does not provide company-wide share count to quantify percentage impact. The filing limits inference to the sales themselves; no other transactions, option exercises, or derivative positions are reported.